These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30363472)

  • 61. Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.
    Lee SH; Park SM; Yeo SS; Kwon O; Lee MK; Yoo H; Ahn EK; Jang JY; Jang JH
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054279
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New markers in Parkinson's disease.
    Bougea A
    Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease.
    Bloem BR; Marks WJ; Silva de Lima AL; Kuijf ML; van Laar T; Jacobs BPF; Verbeek MM; Helmich RC; van de Warrenburg BP; Evers LJW; intHout J; van de Zande T; Snyder TM; Kapur R; Meinders MJ
    BMC Neurol; 2019 Jul; 19(1):160. PubMed ID: 31315608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mass spectrometry for the detection of potential psychiatric biomarkers.
    Ngounou Wetie AG; Sokolowska I; Wormwood K; Beglinger K; Michel TM; Thome J; Darie CC; Woods AG
    J Mol Psychiatry; 2013; 1(1):8. PubMed ID: 25408901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A different vision of translational research in biomarker discovery: a pilot study on circulatory mitochondrial proteins as Parkinson's disease potential biomarkers.
    Anjo SI; Dos Santos PV; Rosado L; Baltazar G; Baldeiras I; Pires D; Gomes A; Januário C; Castelo-Branco M; Grãos M; Manadas B
    Transl Neurodegener; 2020; 9():11. PubMed ID: 32266064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le W; Dong J; Li S; Korczyn AD
    Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Concept of Prodromal Parkinson's Disease.
    Mahlknecht P; Seppi K; Poewe W
    J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson's Disease.
    Anil K; Hall SD; Demain S; Freeman JA; Ganis G; Marsden J
    Brain Sci; 2021 Sep; 11(10):. PubMed ID: 34679358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker.
    Ramaswamy P; Yadav R; Pal PK; Christopher R
    Ann Indian Acad Neurol; 2020; 23(1):84-97. PubMed ID: 32055127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-mammalian animal models of Parkinson's disease for drug discovery.
    Lim KL
    Expert Opin Drug Discov; 2010 Feb; 5(2):165-76. PubMed ID: 22822916
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Approaches to closed-loop deep brain stimulation for movement disorders.
    Kuo CH; White-Dzuro GA; Ko AL
    Neurosurg Focus; 2018 Aug; 45(2):E2. PubMed ID: 30064321
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
    Merchant KM; Cedarbaum JM; Brundin P; Dave KD; Eberling J; Espay AJ; Hutten SJ; Javidnia M; Luthman J; Maetzler W; Menalled L; Reimer AN; Stoessl AJ; Weiner DM;
    J Parkinsons Dis; 2019; 9(1):31-61. PubMed ID: 30400107
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Therapy of Parkinson's Disease Subtypes.
    Marras C; Chaudhuri KR; Titova N; Mestre TA
    Neurotherapeutics; 2020 Oct; 17(4):1366-1377. PubMed ID: 32749651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
    Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
    BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.